Ozdemir, I.Selamoglu, Z.Ates, B.Gok, Y.Yilmaz, I.2024-08-042024-08-0420070301-12080975-0959https://hdl.handle.net/11616/103708The protective role of two synthetic organoselenium compounds 1-isopropyl-3-methylbenzimidazole-2-selenone (SeI) and 1, 3-di-p-methoxybenzylpyrimidine-2-selenone (Sell) was examined against the 7,12-dimethylbenz[a]anthracene (DMBA)-induced changes in biochemical parameters in blood of rats. Albino Winstar rats (150-200 g body wt) were treated with single dose of DMBA (50 mg/kg body wt) and organoselenium compounds (25 mu mol/kg) for 4 weeks at two days internal. Blood was taken from the anaesthetized rats ventricle from their hearts for biochemical analysis. Administration of DMBA resulted in elevation of urea, uric acid and creatinine levels as well as AST, ALT and LDH activities and decrease in levels of total proteins, albumin and globulin. Set and Sell caused I significant (p<0.05) decrease ill Urea, uric acid and creatinine levels and alanine aminotransferase (ALT); aspartate aminotransferase; (AST) and lactate dehydrogenase (LDH) activities and significantly increased the levels of total protein and albumin (p<0.05). These organoselenium compounds are likely to be beneficial in human health.eninfo:eu-repo/semantics/closedAccessbiochemical parameters7,12-dimethylbenz [a]anthracene or DMBAoxidative stressorganoselenium compoundsArticle44425725917970285WOS:000250118400010Q4